title: [Infliximab therapy in Crohn's disease complicated by Listeria monocytogenes meningoencephalitis].
authors.forename: Rado Manitrala
authors.initials: RM
authors.lastname: Ramanampamonjy
authors.forename: David
authors.initials: D
authors.lastname: Laharie
authors.forename: Barbara
authors.initials: B
authors.lastname: Bonnefoy
authors.forename: Julien
authors.initials: J
authors.lastname: Vergniol
authors.forename: Michel
authors.initials: M
authors.lastname: Amouretti
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003424:Crohn Disease / Q000150:complications* / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D000069285:Infliximab; D008089:Listeria monocytogenes; D008088:Listeriosis / Q000150:complications*; D008297:Male; D008590:Meningoencephalitis / Q000150:complications / Q000382:microbiology*
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab